News items Radboudumc and KNAW join the Netherlands Centre for One Health
11 January 2018

Radboud University Medical Center (Radboudumc) and the Royal Netherlands Academy of Arts and Sciences (KNAW) have joined the Netherlands Centre for One Health (NCOH) as Partner as per 1 January 2018. NCOH unites experts from Utrecht University, University Medical Center Utrecht, Wageningen University and Research, Erasmus Medical Center Rotterdam, Academic Medical Center Amsterdam, Leiden University, and Leiden University Medical Center in the areas of human and animal health, thereby forming a strong academic network on infectious diseases in the Netherlands.

Infectious diseases have an increasingly large impact on the health of humans and animals worldwide, including densely-populated countries like the Netherlands. In 2050, about ten million people are predicted to die worldwide from antibiotic-resistant bacterial infections alone if we do not find new solutions, while viral infections are also spreading at an alarming rate. The four NCOH strategic research themes  focus on studying the interactions and connections between human, veterinary, wildlife, and environmental health in pursuit of durable solutions to the grand societal challenges requiring a One Health approach.

“To find new solutions to combat infectious diseases, like the issue of antimicrobial resistance, we need a holistic view and a multidisciplinary approach, which is an important reason for us to join NCOH”, says professor Heiman Wertheim, clinical microbiologist and chair of the Radboud Center of Infectious Diseases. “At Radboudumc we have a strong research theme on infectious diseases and global health with operational multidisciplinary research networks worldwide. Recently we recruited a PhD student as part of the NCOH collaboration who will work on fungal infections where antimicrobial resistance is a major, but often neglected, issue. We look forward to contribute to NCHOH, learn from each other and conduct relevant research together.”

The Royal Netherlands Academy of Arts and Sciences (KNAW) will participate in NCOH through three of its institutes that are thematically linked to the NCOH Strategic Research Agenda: Westerdijk Fungal Biodiversity Institute, Hubrecht Institute for Developmental Biology & Stem Cell Research, and Netherlands Institute of Ecology (NIOO).

“With Radboudumc and the KNAW both joining the NCOH as a partner, the leading academic research institutes will now form an even stronger academic network on infectious diseases in the Netherlands. NCOH is indeed a joint scientific force further tackling One Health issues in public health, animal health, food production and the environment, with an integrated and interdisciplinary approach”, says Martin Scholten, chairman of the NCOH Supervisory Board.

More information about NCOH

Solutions to Global One Health Challenges. The Netherlands Centre for One Health (NCOH) bundles top-leading academic research institutes in the Netherlands in an open innovation network focused on One Health: public, veterinary, wildlife, and ecosystems health. It aims for an integrated approach to face the global risk of infectious diseases and to develop durable solutions regarding grand societal health challenges. This virtual science-driven institution focuses its research and increase of knowledge on antibiotic resistance, emerging infectious diseases, smart farming, and healthy ecosystems. The NCOH stimulates collaboration between academic and research institutes, governments, NGOs, public health institutes, and industrial partners. The NCOH partners are Academic Medical Center Amsterdam, Erasmus Medical Center Rotterdam, Leiden University, Leiden University Medical Center, Radboud University Medical Center, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht University, and Wageningen University and Research.

Related news items


650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more

Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation. 

29 July 2020

These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.

read more

Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process

28 July 2020

''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.

read more